3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
11
Stomach Neoplasms
4
Prostatic Neoplasms
4
Polycystic Ovary Syndrome
4
Neoplasms
3
Lung Neoplasms
3
Peripheral Nervous System Diseases
2
Inflammation
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Intraductal, Noninfiltrating
2
Weight Loss
1
Rectal Neoplasms
1
Psychological Well-Being
1
Psoriasis
1
Protein Deficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Obesity
1
Neoplasm, Residual
1
Multiple Sclerosis
1
Motor Activity
1
Malnutrition
1
Lipid Metabolism Disorders
1
Infections
1
Healthy Subject
1
Interventions
Metformin
8
Nutrition Assessment
3
Methods
3
Exercise
3
Educational Status
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Resistance Training
2
tocilizumab
1
tislelizumab
1
sofosbuvir-velpatasvir drug combination
1
saxagliptin
1
otelixizumab
1
esmolol
1
epalrestat
1
donafenib
1
dapagliflozin
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Surveys and Questionnaires
1
Standard of Care
1
Secretin
1
Second Harmonic Generation Microscopy
1
Risk Assessment
1
Remote Consultation
1
Preventive Health Services
1
Practice Guidelines as Topic
1
Patient Navigation
1
Pancreaticoduodenectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Diabetes Mellitus
×
Fish Oils
×
Clear all
NCT04116203
2025-02-28
PCOS
University of Alberta
Phase 1
Completed
52 enrolled